Cardinal Health dba Specialty Pharmaceutical Services

FDA Regulatory Profile

Cardinal Health dba Specialty Pharmaceutical Services appears in FDA public data with 1 recall, 0 510(k) clearances, 4 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-1876-2019, Class II) was initiated on September 6, 2019.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
4
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-1876-2019Class IINucala (mepolizumab) Injection, 100 mg/mL Prefilled Syringe, Single-Dose, For subcutaneous use only,September 6, 2019